Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Seiwerth

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Digestive Diseases and Sciences|July 1, 1996
Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in ratsP Sikirić, S Seiwerth, Z Grabarević, et al.
Journal of Physiology, Paris|February 15, 2000
Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and miceM Petek, P Sikiric, T Anic, et al.
Digestive Diseases and Sciences|August 1, 1996
Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicityP Sikirić, S Seiwerth, Z Grabarević, et al.
Digestive Diseases and Sciences|March 1, 1997
Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stressP Sikirić, B Mazul, S Seiwerth, et al.
Burns : Journal of the International Society for Burn Injuries|November 24, 2001
Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in miceD Mikus, P Sikiric, S Seiwerth, et al.
Journal of Physiology, Paris|October 12, 2001
Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidineI Prkacin, J Separovic, G Aralicia, et al.
Journal of Physiology, Paris|May 1, 1997
Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in ratsP Sikiric, S Seiwerth, Z Grabarevic, et al.
Digestive Diseases and Sciences|May 1, 1997
Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studiesP Sikirić, D Mikus, S Seiwerth, et al.
Journal of Physiology, Paris|May 3, 2000
Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157P Sikiric, J Separovic, G Buljat, et al.
European Journal of Pharmacology|July 30, 1997
The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressureP Sikirić, S Seiwerth, Z Grabarević, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Digestive Diseases and Sciences|July 1, 1996
Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in ratsP Sikirić, S Seiwerth, Z Grabarević, et al.
Journal of Physiology, Paris|February 15, 2000
Pentadecapeptide BPC 157 attenuates gastric lesions induced by alloxan in rats and miceM Petek, P Sikiric, T Anic, et al.
Digestive Diseases and Sciences|August 1, 1996
Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicityP Sikirić, S Seiwerth, Z Grabarević, et al.
Digestive Diseases and Sciences|March 1, 1997
Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stressP Sikirić, B Mazul, S Seiwerth, et al.
Burns : Journal of the International Society for Burn Injuries|November 24, 2001
Pentadecapeptide BPC 157 cream improves burn-wound healing and attenuates burn-gastric lesions in miceD Mikus, P Sikiric, S Seiwerth, et al.
Journal of Physiology, Paris|October 12, 2001
Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by stable gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidineI Prkacin, J Separovic, G Aralicia, et al.
Journal of Physiology, Paris|May 1, 1997
Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agent-induced gastrointestinal lesions and adjuvant arthritis in ratsP Sikiric, S Seiwerth, Z Grabarevic, et al.
Digestive Diseases and Sciences|May 1, 1997
Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studiesP Sikirić, D Mikus, S Seiwerth, et al.
Journal of Physiology, Paris|May 3, 2000
Gastric mucosal lesions induced by complete dopamine system failure in rats. The effects of dopamine agents, ranitidine, atropine, omeprazole and pentadecapeptide BPC 157P Sikiric, J Separovic, G Buljat, et al.
European Journal of Pharmacology|July 30, 1997
The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressureP Sikirić, S Seiwerth, Z Grabarević, et al.
Pageof 8